Check-Cap Ltd. (NASDAQ:CHEK), a medical diagnostics company, disclosed today that it has received a notice of non-compliance from Nasdaq due to its failure to file the required annual financial report. The notice, dated May 21, 2025, indicates the company’s non-compliance with the Nasdaq Listing Rule 5250(c)(1), which mandates timely filing of periodic financial reports.
The delinquency pertains to Check-Cap’s Annual Report on Form 20-F for the year ended December 31, 2024, which has not been filed with the Securities and Exchange Commission (SEC). Nasdaq has provided the company with a 60-day deadline, until July 21, 2025, to submit a plan to regain compliance regarding the delinquent Form 20-F.
If the compliance plan is accepted by Nasdaq, Check-Cap may be granted an extension of up to 180 calendar days from the original due date of the Form 20-F, potentially until November 11, 2025, to file the report and regain compliance. Should Nasdaq reject the plan, Check-Cap will have the opportunity to appeal the decision before a Nasdaq Hearings Panel.
The company has expressed its intention to work diligently to file the overdue Form 20-F as promptly as possible and to submit the compliance plan to Nasdaq without delay. This announcement is incorporated by reference into Check-Cap’s Registration Statements on Form F-3 and Form S-8 filed with the SEC.
The information in this article is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.